MicroRNAs (miRNAs) are short (18-26 nt), non-coding RNAs that function as post-transcriptional silencers of gene expression by binding to complementary sequences in 3'UTRs of target mRNAs. This sequence complementarity suggests that it should be possible to predict which genes might be targeted by a given miRNA and thus deduce its biological function. While it is true that predicted targets, in particular those whose target sites are conserved in closely related species, are typically enriched in the class of genes upregulated following disruption of the cognate miRNA, the biological significance of these minor changes in target expression (generally <2-fold) remains an open question for nearly all miRNAs. Very few studies approach the question of target recognition genetically, identifying targets by their suppression or phenocopy of the miRNA mutant phenotype. This approach would seem better suited to identifying biologically and evolutionarily relevant targets. >In the C. elegans community, we are fortunate to have access to a comprehensive library of miRNA knockout strains. Here, we use one of these mutant strains to study the function of
mir-232, a previously uncharacterized miRNA gene conserved within ecdysozoa and lophotrochozoa. From observations of the
mir-232 knockout strain, we have found that
mir-232 is cell-autonomously required for the normal morphogenesis of the excretory canal cell, one quarter of the four-cell osmoregulatory apparatus of the animal and, as we have found, the primary site of miR-232 expression. Using a candidate approach, we have identified the glucuronyltransferase SQV-8, part of the glycosaminoglycan biosynthetic pathway, as a direct target of miR-232 in the excretory cell, whose ectopic expression at least partially accounts for abnormal canal extension in
mir-232 mutant animals. Consistent with the targeting of
sqv-8, we reproducibly detect changes to the profile of chondroitin-modified proteins in
mir-232 mutant animals. Ongoing work seeks to address additional aspects of this biology, including the temporal requirements of
mir-232 during excretory cell morphogenesis, the functional consequences of this abnormal morphogenesis with respect to osmoregulation, and the physiological consequences of hyperactive glycosaminoglycan biosynthesis in the excretory cell, in an attempt to integrate the phenotypic and targeting data into a coherent model of miR-232 function. Progress on each of these fronts will be presented.